Outstanding phenotypic differences in the profile of amyloid-β between Tg2576 and APPswe/PS1dE9 transgenic mouse models of Alzheimer’s disease

Manuscript Number: 

16-0280R1

Author(s): 
José Antonio Allué, Noelia Fandos, María Izco, Samuel Ogueta, María Pascual-Lucas, Pedro Pesini, Virginia Pérez-Grijalba, Leticia Sarasa, Manuel Sarasa

Disclosures

José Antonio Allué

  • Nothing to Disclose

Noelia Fandos

  • Nothing to Disclose

María Izco

  • Nothing to Disclose

Samuel Ogueta

  • Nothing to Disclose

María Pascual-Lucas

  • Nothing to Disclose

Virginia Pérez-Grijalba

  • Nothing to Disclose

Pedro Pesini

  • Sponsors:
    Director R&D

Manuel Sarasa

  • Equity:
    I am the scientific founder (2004) and one of the current shareholders of Araclon Biotech Ltd.
    Sponsors:
    President, CEO and CSO of Araclon Biotech Ltd.
    Patents/Royalties
    I have invented patents related to Alzheimer's disease diagnosis and treatment with Araclon Biotech Ltd.

Leticia Sarasa

  • Nothing to Disclose